KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Profit After Tax: 2010-2025

Historic Profit After Tax for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to $152,000.

  • TherapeuticsMD's Profit After Tax rose 124.96% to $152,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $171,000, marking a year-over-year increase of 105.04%. This contributed to the annual value of -$2.3 million for FY2024, which is 77.51% up from last year.
  • According to the latest figures from Q3 2025, TherapeuticsMD's Profit After Tax is $152,000, which was down 72.41% from $551,000 recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Profit After Tax peaked at $159.4 million during Q4 2022, and registered a low of -$49.0 million during Q1 2022.
  • Moreover, its 3-year median value for Profit After Tax was -$809,000 (2024), whereas its average is -$1.1 million.
  • As far as peak fluctuations go, TherapeuticsMD's Profit After Tax surged by 470.99% in 2022, and later tumbled by 102.15% in 2023.
  • Over the past 5 years, TherapeuticsMD's Profit After Tax (Quarterly) stood at -$43.0 million in 2021, then skyrocketed by 470.99% to $159.4 million in 2022, then crashed by 100.55% to -$883,000 in 2023, then soared by 113.70% to $121,000 in 2024, then spiked by 124.96% to $152,000 in 2025.
  • Its Profit After Tax stands at $152,000 for Q3 2025, versus $551,000 for Q2 2025 and -$653,000 for Q1 2025.